Skip to main content

RHUMBLINE ADVISERS

Position in RLMD — Relmada Therapeutics, Inc.

CIK 1115418 BOSTON, MA

Position in RLMD

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$817,307
+$813,932 QoQ
Shares Held
118,108
+10398.5% QoQ
Ownership
0.111%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#57
of 126 holders
Holding Since
Jun 2020
18 quarters on record
Voting authority Sole 21% Shared 0% None 79%

Common Shares in RLMD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,414,750,230 across 329 Biotechnology names. RLMD ranks #152 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RLMD

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $817,307 118,108
2024-06-30 $3,375 1,125
2024-03-31 $5,459 1,174
2023-12-31 $4,860 1,174
2023-09-30 $3,522 1,174
2023-06-30 $8,482 3,448
2023-03-31 $85,055 37,635
2022-12-31 $127,535 36,543
2022-09-30 $1,342,456 36,263
2022-06-30 $634,930 33,435
2022-03-31 $581,877 21,559
2021-12-31 $351,107 15,584
2021-09-30 $414,799 15,826
2021-06-30 $485,047 15,153
2021-03-31 $577,197 16,393
2020-12-31 $549,294 17,128
2020-09-30 $601,844 15,998
2020-06-30 $798,474 17,843